These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 224397

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Diet and drug treatment of hyperlipidemia and atherosclerosis.
    Kuo PT.
    Ann Clin Lab Sci (1971); 1972; 2(4):322-4. PubMed ID: 4342101
    [No Abstract] [Full Text] [Related]

  • 5. Xanthomatosis and hyperlipoproteinemia; a review.
    Polano MK.
    Dermatologica; 1974; 149(1):1-9. PubMed ID: 4372111
    [No Abstract] [Full Text] [Related]

  • 6. Bile acid metabolism in hyperlipoproteinaemia.
    Hellström K, Einarsson K.
    Clin Gastroenterol; 1977 Jan; 6(1):103-28. PubMed ID: 196796
    [No Abstract] [Full Text] [Related]

  • 7. Dietary and drug treatment of primary hyperlipoproteinemia.
    Ann Intern Med; 1972 Aug; 77(2):267-94. PubMed ID: 4345081
    [No Abstract] [Full Text] [Related]

  • 8. Should hyperlipoproteinemia be treated in patients with coronary artery disease?
    Rider AK.
    JAMA; 1975 Jul 21; 233(3):275-7. PubMed ID: 168412
    [No Abstract] [Full Text] [Related]

  • 9. [Lipid-lowering drugs. Therapeutics and adverse effects].
    Vogelberg KH.
    Med Klin; 1979 Aug 10; 74(32-33):1171-8. PubMed ID: 224293
    [No Abstract] [Full Text] [Related]

  • 10. Does hypolipidemic therapy prevent coronary heart disease?
    Rifkind BM, Levy RI.
    Cardiovasc Clin; 1974 Aug 10; 6(2):1-8. PubMed ID: 4374303
    [No Abstract] [Full Text] [Related]

  • 11. Therapy of hyperlipidemic states.
    Havel RJ, Kane JP.
    Annu Rev Med; 1982 Aug 10; 33():417-33. PubMed ID: 7044276
    [No Abstract] [Full Text] [Related]

  • 12. [Effect of a new synthetic compound (3-nicotinoyl-oxypropyl p-chlorophenoxy isobutyrate: I.612) on plasma lipids in patients with type IIa, IIb and IV hyperdyslipidemia].
    Bucalossi A, Buzzelli G, D'Alessandro A.
    Clin Ter; 1979 Apr 30; 89(2):127-49. PubMed ID: 226307
    [No Abstract] [Full Text] [Related]

  • 13. [Therapy of primary hyperlipemia].
    Schneider J, Kaffarnik H.
    Dtsch Med Wochenschr; 1971 May 07; 96(19):831-2. PubMed ID: 5574353
    [No Abstract] [Full Text] [Related]

  • 14. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
    Orö L, Olsson AG, Rössner S, Carlson LA.
    Postgrad Med J; 1975 May 07; 51(8):76-81. PubMed ID: 176639
    [No Abstract] [Full Text] [Related]

  • 15. [Dietetic and drug therapy of hyperlipidemias and hyperlipoproteinemia].
    Huth K, Blumenthal J, Schmahl FW.
    Med Klin; 1973 Aug 24; 68(34):1089-97. PubMed ID: 4790868
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A physician's guide to hyperlipidemia.
    Fredrickson DS.
    Mod Concepts Cardiovasc Dis; 1972 Jul 24; 41(7):31-6. PubMed ID: 4343098
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Current trends in the therapy of arteriosclerotic disease].
    Toscano S.
    G Clin Med; 1974 Jan 24; 55(1):27-39. PubMed ID: 4369524
    [No Abstract] [Full Text] [Related]

  • 20. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
    Orö L, Olsson AG, Rössner S, Carlson LA.
    Postgrad Med J; 1975 Jan 24; 51(8):suppl 76-81. PubMed ID: 215986
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.